Nevertheless, their overall response to the agonists and antagonists provides evidence to support the potential importance of the MAPK JNK/p38 signaling in Gal-1 mediated EMT and metastasis in ovarian cancer. The gene discussed is GAL; the disease is ovarian carcinoma.